DEF: Avient Sets 2026 Shareholder Meeting, Details Governance & Pay

Avient Corporation announces its 2026 Annual Meeting of Shareholders, outlining director nominees, executive compensation, and corporate governance updates, following a year of strategic execution and debt reduction.

Summary

• The 2026 Annual Meeting of Shareholders will be held virtually on Thursday, May 14, 2026, at 9:00 a.m. Eastern Time.
• Shareholders will vote on the election of eleven director nominees, advisory approval of Named Executive Officer (NEO) compensation, and ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026.
• The company's strategy, defined in 2024, focuses on organic growth through innovation in high-growth markets and maximizing value from the existing portfolio, complemented by M&A.
• In 2025, sales were relatively flat year-over-year at $3.26 billion, but adjusted EBITDA margin expanded, and adjusted EPS grew to $2.82 from $2.66 in 2024.
• Disciplined cash management generated free cash flow, enabling a $150 million reduction in outstanding debt.
• The Board reviewed its leadership structure in 2025, recombining the Chairman and CEO roles, with Dr. Ashish K. Khandpur serving as both, and Richard H. Fearon appointed as Lead Director.
• Executive compensation programs are designed to be pay-for-performance, with 2025 annual incentive payouts based on adjusted operating income, revenue growth, adjusted operating cash flow, and sustainability objectives.
• Long-term incentive awards for 2025 included time-based Restricted Stock Units (RSUs) and cash-settled performance units tied to adjusted EPS and relative Total Shareholder Return (rTSR) over a three-year period.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive. While the company demonstrated strong adjusted EPS growth and debt reduction in a challenging environment, the significant decline in GAAP EPS and missed revenue/segment operating income targets for executive incentives temper the overall optimism. The strategic shift and innovation focus are promising long-term drivers.

Positives

• Adjusted EBITDA margin expanded in 2025 compared to 2024, driven by productivity initiatives, product mix, and positive results from prioritized growth vectors.
• Adjusted EPS grew to $2.82 in 2025 from $2.66 in 2024, despite a challenging macroeconomic environment.
• Generated strong operating cash flow of $302 million, leading to a $150 million reduction in outstanding debt.
• Increased the annual dividend by 2% to $1.10, marking the 15th consecutive year of increase.
• Successful implementation of a new strategy focused on organic growth, innovation, and maximizing existing portfolio value, with growth vector sales outpacing the rest of the company (defense and healthcare leading).
• Increased internal R&D collaboration and bolstered digital capabilities, including piloting artificial intelligence tools.
• Recruited and retained top talent, strengthening company culture with new Avient Leadership Behaviors.
• Maintained ACC Responsible Care certification and an EcoVadis Silver sustainability rating.
• Received over 92% shareholder approval for executive compensation at the 2025 Annual Meeting.
• Maintains robust stock ownership guidelines for directors and executives, aligning interests with shareholders.

Negatives

• Sales were relatively flat year-over-year in 2025, growing only 1% to $3.26 billion from $3.24 billion in 2024.
• GAAP earnings per share (EPS) decreased significantly to $0.89 in 2025 from $1.84 in 2024.
• Certain sustainability metrics for the 2025 Annual Incentive Program (waste to landfill intensity and weather-adjusted energy intensity) were not achieved.
• The Color, Additives and Inks (CAI) business segment did not achieve its Adjusted Operating Income or Revenue Growth thresholds for the 2025 Annual Incentive Program.
• The Specialty Engineered Materials (SEM) business segment did not achieve its Adjusted Operating Income or Revenue Growth thresholds for the 2025 Annual Incentive Program.
• The 2023-2025 cash-settled performance units achieved only 20% of the target level performance, indicating underperformance against long-term adjusted EPS goals for that period.

Risks

• Disruptions, uncertainty, or volatility in global credit markets could adversely impact the availability and cost of credit.
• Foreign operations are subject to currency fluctuations, tariffs, and other political, economic, and regulatory risks.
• Disruptions or inefficiencies in the supply chain, logistics, or operations could occur.
• Changes in laws and regulations in jurisdictions where business is conducted, particularly concerning plastics and climate change, could impact operations.
• Changes to foreign trade policy, including new or increased tariffs and changing import/export regulations, pose risks.
• Fluctuations in raw material prices, quality, and supply, as well as energy prices and supply, could affect profitability.
• Demand for products and services may fluctuate.
• Production outages or material costs associated with scheduled or unscheduled maintenance programs could arise.
• Unanticipated developments could occur with respect to contingencies such as litigation and environmental matters.
• The ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends are not guaranteed.
• Information systems failures, cybersecurity breaches, and cyberattacks are potential threats.
• The ability to service indebtedness and restrictions on current and future operations due to indebtedness are ongoing concerns.
• Amounts for cash and non-cash charges related to restructuring plans may differ from original estimates due to timing changes.
• Other factors beyond the company's control, including changes in the general economy, interest rates, inflation, geopolitical conflicts, and recessionary conditions, could affect the business.
• Additional risk factors are described in the Annual Report on Form 10-K for the year ended December 31, 2025, under Item 1A, Risk Factors.

Future Outlook

Innovation will remain the bedrock of Avient's strategy in 2026 and beyond, and will be key to accelerating growth and profitability. The company plans to continue investing in differentiated solutions to address customer needs in high-growth markets, anticipating that the 'flywheel of innovation' will multiply success. Supported by a strong history of operational execution and financial discipline, Avient is confident that 2026 will continue its trajectory of positive financial and operating results. Specific forward-looking adjusted EPS goals for 2025-2027 cash-settled performance units are expected to be disclosed in future proxy statements once the applicable performance periods have ended.

Management Comments

• "The conclusion of 2025 marked the end of my second full year as Chief Executive Officer of Avient, and we have been working to evolve the company since I joined."
• "Over this period, we have changed our strategic focus and strengthened execution across the organization."
• "While Avients growth story historically had been centered around merger and acquisition activities as a means to change our portfolio mix, our strategy today focuses primarily on organic growth powered by innovating in the right spaces, with M&A complementing our growth efforts, as needed."
• "Over the last two years our prioritized growth vectors have delivered substantial growth, and our innovation has resulted in differentiated products."
• "Our concentrated efforts to drive profitability, consistently delivering top-line revenue growth and margin expansion on the bottom line, have also taken hold."
• "Looking specifically at 2025, while sales were relatively flat year-over-year, we delivered adjusted EBITDA margin expansion compared to 2024, with productivity initiatives, product mix, and positive results from our prioritized growth vectors enabling this expansion."
• "Adjusted EPS grew compared to last year."
• "Disciplined cash management helped generate free cash flow for our company that enabled us to reduce our outstanding debt by $150 million."
• "These positive financial results are particularly noteworthy given the challenging macro business environment in which we were operating, which was marked by unprecedented trade dynamics, inflationary pressures, and lower consumer confidence."
• "Innovation will remain the bedrock of our strategy at Avient in 2026 and beyond, and will be key to accelerating growth and profitability for the company and our shareholders."
• "As our flywheel of innovation gains momentum, we anticipate the success that we have already seen will multiply."
• "Supported by Avient's strong history of operational execution and financial discipline, we are confident that 2026 will continue our trajectory of positive financial and operating results."

Industry Context

The filing highlights Avient's strategic shift towards organic growth and innovation in high-growth markets like defense and healthcare, moving away from a primary M&A-driven growth model. StockSavvy.ai notes this aligns with a broader industry trend where specialty chemical and materials companies are increasingly focusing on differentiated, high-value solutions and sustainability to drive growth amidst mature markets and increasing regulatory scrutiny on traditional plastics. The emphasis on digital initiatives and AI tools also reflects a wider industry push for operational efficiency and advanced product development. The challenging macroeconomic environment mentioned (trade dynamics, inflation, lower consumer confidence) is a common theme across many industrial sectors, making Avient's adjusted EPS growth and debt reduction noteworthy.

Comparison to Industry Standards

• Avient's 2025 adjusted EPS growth to $2.82 from $2.66 in 2024, alongside flat sales, suggests effective cost management and margin expansion in a challenging environment, which can be a strong performance indicator compared to peers like Ashland Global Holdings Inc., Eastman Chemical Company, and Celanese Corporation, especially if they faced similar market headwinds.
• The 15th consecutive year of dividend increase to $1.10 annualized demonstrates a consistent commitment to shareholder returns, a strong indicator of financial health and stability that often surpasses the dividend policies of many industrial and materials companies.
• The $150 million debt reduction in 2025 is a positive sign of financial discipline, particularly when compared to companies that might be increasing leverage in the current interest rate environment, showcasing a conservative financial approach.
• The adoption of relative Total Shareholder Return (rTSR) as a performance metric for long-term incentives, benchmarked against its peer group (including companies like Cabot Corporation and H.B. Fuller Company), directly ties executive compensation to relative shareholder performance, a practice common among leading industrial and materials companies to align management with investor interests.

Management Changes

Corporate Governance

Related Party Transactions

• There were no related person transactions in 2025.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through the organic growth and innovation strategy, continued dividend increases, and improved financial stability from debt reduction. However, flat sales and declining GAAP EPS could be a concern.
• Employees: Focus on recruiting and retaining top talent, strengthening company culture, and digital initiatives to increase operational effectiveness. Compensation programs are designed to attract, motivate, and retain a high-performing team.
• Customers: The company's strategy emphasizes being an 'innovator of materials solutions to help our customers succeed,' with continued investment in differentiated solutions to address customer needs.
• Creditors: The $150 million debt reduction improves the company's credit profile and financial health. The ability to service indebtedness is a recognized risk factor, but current actions are positive.
• Suppliers: Potential for supply chain disruptions is noted as a risk, which could indirectly impact supplier relationships and operations.

Next Steps

• Shareholders are invited to attend and participate in the 2026 Annual Meeting of Shareholders virtually on May 14, 2026.
• Shareholders will vote on the election of eleven director nominees, advisory approval of Named Executive Officer compensation, and ratification of Ernst & Young LLP as the independent registered public accounting firm.
• The company will continue to invest in differentiated solutions to help address customer needs in high-growth markets in 2026 and beyond.
• The Compensation Committee expects to consider the results from this year's and future advisory votes on named executive officer compensation.
• The next advisory Say on Pay vote is expected to occur in 2027.
• The next advisory vote on the frequency of the advisory vote on Named Executive Officer compensation is anticipated to occur at the 2029 Annual Meeting.
• The company expects to disclose specific forward-looking adjusted EPS goals for the 2025-2027 cash-settled performance units in future proxy statements once the applicable performance periods have ended.

Key Dates

Recommendation

Avient's strategic pivot towards organic growth and innovation, coupled with adjusted EPS growth and significant debt reduction in a challenging macro environment, are positive indicators. However, flat sales and a notable decline in GAAP EPS, along with missed performance targets for executive incentives, suggest ongoing challenges. The company is executing a long-term strategy, but the immediate financial picture is mixed, warranting a 'hold' as the market assesses the full impact of the strategic transformation.

Keywords

Avient Corporation, Proxy Statement, Corporate Governance, Executive Compensation, Director Nominees, Shareholder Meeting, Financial Performance, Adjusted EPS, Debt Reduction, Sustainability, Materials Solutions, Specialty Chemicals, Risk Management, Innovation, Organic Growth, Board of Directors